Loratadine analogues as MAGL inhibitors.

Compound 12a (JZP-361) acted as a potent and reversible inhibitor of human recombinant MAGL (hMAGL, IC50=46 nM), and was found to have almost 150-fold higher selectivity over human recombinant fatty acid amide hydrolase (hFAAH, IC50=7.24 μM) and 35-fold higher selectivity over human α/β-hydrolase-6 (hABHD6, IC50=1.79 μM). Additionally, compound 12a retained H1 antagonistic affinity (pA2=6.81) but did not show cannabinoid receptor activity, when tested at concentrations ⩽ 10 μM. Hence, compound 12a represents a novel dual-acting pharmacological tool possessing both MAGL-inhibitory and antihistaminergic activities.

[1]  J. Laitinen,et al.  An optimized approach to study endocannabinoid signaling: evidence against constitutive activity of rat brain adenosine A1 and cannabinoid CB1 receptors , 2003, British journal of pharmacology.

[2]  C. Guaza,et al.  A reversible and selective inhibitor of monoacylglycerol lipase ameliorates multiple sclerosis. , 2014, Angewandte Chemie.

[3]  J. Wouters,et al.  Disulfiram is an Inhibitor of Human Purified Monoacylglycerol Lipase, the Enzyme Regulating 2‐Arachidonoylglycerol Signaling , 2007, Chembiochem : a European journal of chemical biology.

[4]  J. Clemente,et al.  Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution , 2011, Protein science : a publication of the Protein Society.

[5]  Patrice D Cani,et al.  Increasing endogenous 2‐arachidonoylglycerol levels counteracts colitis and related systemic inflammation , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  J. Laitinen,et al.  Characterization of binding properties of monoglyceride lipase inhibitors by a versatile fluorescence-based technique. , 2010, Analytical biochemistry.

[7]  M. Mor,et al.  A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone‐based enzyme inhibitors , 2009, British journal of pharmacology.

[8]  Antti Poso,et al.  Identification of WIN55212‐3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor , 2005, British journal of pharmacology.

[9]  B. Cravatt,et al.  A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2‐Arachidonoylglycerol , 2007, Chemistry & biology.

[10]  G. Muccioli,et al.  Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. , 2009, Journal of medicinal chemistry.

[11]  Z. Vogel,et al.  Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. , 1995, Biochemical pharmacology.

[12]  J. Long,et al.  Characterization of tunable piperidine and piperazine carbamates as inhibitors of endocannabinoid hydrolases. , 2010, Journal of medicinal chemistry.

[13]  Peng-Fei Wang,et al.  Stereoselective synthesis of desloratadine derivatives as antagonist of histamine. , 2010, Bioorganic & medicinal chemistry.

[14]  A. Poso,et al.  1,3,4-Oxadiazol-2-ones as fatty-acid amide hydrolase and monoacylglycerol lipase inhibitors: Synthesis, in vitro evaluation and insight into potency and selectivity determinants by molecular modelling. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[15]  Stefan Wetzel,et al.  Small-molecule inhibition of APT1 affects Ras localization and signaling. , 2010, Nature chemical biology.

[16]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[17]  J. Gertsch,et al.  The antinociceptive triterpene β‐amyrin inhibits 2‐arachidonoylglycerol (2‐AG) hydrolysis without directly targeting cannabinoid receptors , 2012, British journal of pharmacology.

[18]  J. Poupaert,et al.  Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors. , 2009, Journal of medicinal chemistry.

[19]  Peter T. Nguyen,et al.  Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system , 2010, Nature Neuroscience.

[20]  T. Nevalainen,et al.  Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors. , 2010, Current topics in medicinal chemistry.

[21]  J. Poupaert,et al.  Insight into the medicinal chemistry of the endocannabinoid hydrolase inhibitors. , 2013, Current medicinal chemistry.

[22]  L. Parsons,et al.  Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates. , 2012, Chemistry & biology.

[23]  L. Parsons,et al.  Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. , 2013, ACS chemical neuroscience.

[24]  J. Leppänen,et al.  Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. , 2008, Journal of medicinal chemistry.

[25]  T. Freund,et al.  Brain monoglyceride lipase participating in endocannabinoid inactivation , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G. Ortar,et al.  Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold. , 2012, Bioorganic & medicinal chemistry.

[27]  J. Laitinen,et al.  Biochemical and pharmacological characterization of human α/β-hydrolase domain containing 6 (ABHD6) and 12 (ABHD12)[S] , 2012, Journal of Lipid Research.

[28]  A. Yamashita,et al.  2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. , 1995, Biochemical and biophysical research communications.

[29]  T. Bisogno,et al.  Development of a potent inhibitor of 2-arachidonoylglycerol hydrolysis with antinociceptive activity in vivo. , 2009, Biochimica et biophysica acta.

[30]  Ruben Abagyan,et al.  Structure of the human histamine H1 receptor complex with doxepin , 2011, Nature.

[31]  J. Laitinen,et al.  The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors , 2012, Acta physiologica.

[32]  T. Laitinen,et al.  Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). , 2014, Bioorganic & medicinal chemistry.

[33]  S. Narumiya,et al.  Prostaglandin E2–EP3 Signaling Induces Inflammatory Swelling by Mast Cell Activation , 2014, The Journal of Immunology.

[34]  D. Nomura,et al.  Inhibition of Monoacylglycerol Lipase Attenuates Nonsteroidal Anti-Inflammatory Drug-Induced Gastric Hemorrhages in Mice , 2011, Journal of Pharmacology and Experimental Therapeutics.

[35]  A. Poso,et al.  Mutation of Cys242 of Human Monoacylglycerol Lipase Disrupts Balanced Hydrolysis of 1-and 2-monoacylglycerols and Selectively Impairs Inhibitor Potency Running Title Page Running Title: Structural Determinants of Magl for Substrate Preference Introduction , 2022 .

[36]  R. Kitz,et al.  Esters of methanesulfonic acid as irreversible inhibitors of acetylcholinesterase. , 1962, The Journal of biological chemistry.

[37]  Daniele Piomelli,et al.  Discovery of potent and reversible monoacylglycerol lipase inhibitors. , 2009, Chemistry & biology.

[38]  J. Poupaert,et al.  Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors. , 2012, Journal of medicinal chemistry.

[39]  H. Schild,et al.  SOME QUANTITATIVE USES OF DRUG ANTAGONISTS , 1997, British journal of pharmacology and chemotherapy.

[40]  M. Mathieu,et al.  Structural basis for human monoglyceride lipase inhibition. , 2010, Journal of molecular biology.

[41]  U. Hellman,et al.  cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase , 1997, The Journal of Biological Chemistry.

[42]  Melinda M. Mulvihill,et al.  Therapeutic potential of monoacylglycerol lipase inhibitors. , 2013, Life sciences.

[43]  G. Muccioli,et al.  Inhibitors of the endocannabinoid-degrading enzymes, or how to increase endocannabinoid's activity by preventing their hydrolysis. , 2012, Recent patents on CNS drug discovery.

[44]  A. Poso,et al.  Piperazine and piperidine triazole ureas as ultrapotent and highly selective inhibitors of monoacylglycerol lipase. , 2013, Chemistry & biology.

[45]  J. Long,et al.  Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2‐arachidonoyl glycerol attenuates nausea in rats , 2012, British journal of pharmacology.

[46]  Henri Xhaard,et al.  Screening of Various Hormone‐Sensitive Lipase Inhibitors as Endocannabinoid‐Hydrolyzing Enzyme Inhibitors , 2009, ChemMedChem.

[47]  B. Cravatt,et al.  Chemical Probes of Endocannabinoid Metabolism , 2013, Pharmacological Reviews.

[48]  Antti Poso,et al.  Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system. , 2006, Journal of medicinal chemistry.